Individualized Novel Therapies for Patients with Tumor Suppressor Genes BRCA1 and BRCA2 Mutated Epithelial Ovarian Cancer
Ovarian cancer is the leading cause of death in women with gynecological cancer, since a large proportion of patients are diagnosed at later stages of the disease. The incidence of ovarian cancer in the general population is 2%, but patients with germline mutations in the BRCA genes have a risk of d...
Saved in:
Main Authors: | García-Nieto, Sandra (Author), Guillén-Ponce, Carmen (Author), Alonso, Carmen (Author), Rodríguez-Soriano (Author), Pombo, María-Luz (Author), Julie, Earl (Author), Farghaly, Samir A. (Author) |
---|---|
Format: | Ebooks |
Published: |
IntechOpen,
2016-03-02.
|
Subjects: | |
Online Access: | Get Online |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of 5382 insС Mutation in BRCA 1 Gene in the Development of Hereditary and Multiple Primary Tumors (Clinical Case)
by: Paliychuk, O. V., et al.
Published: (2015) -
Breast Cancer and <em>BRCA1</em> and <em>BRCA2</em> Pathogenic Variants
by: Basu, Naren, et al.
Published: (2020) -
Chapter Mapping Jewish Identities : Migratory Histories and the Transnational Re-Framing of 'Ashkenazi BRCA Mutations' in the UK and Brazil
by: Mozersky, Jessica
Published: (2014) -
Chapter 8 The BRCA patent controversies : An international review of patent disputes
by: van Zimmeren, Esther
Published: (2014) -
Tumor Suppressor Genes
Published: (2012)